The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty

Journal of Bone and Joint Surgery - Series B

Volumn 89, Issue 4, 2007, Pages 434-440

  Board, Tim N ^a,c   Karva, A ^a,c   Board, R E ^b,c   Gambhir, A K ^a,c   Porter, M L ^a,c  

^a WRIGHTINGTON HOSPITAL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROSTAGLANDIN E2; WARFARIN;

ANKYLOSING SPONDYLITIS; ANTICOAGULATION; ARTICLE; ASTHMA; BONE NECROSIS; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HETEROTOPIC OSSIFICATION; HIGH RISK PATIENT; HUMAN; HYPEROSTOSIS; INCIDENCE; KIDNEY DISEASE; KNEE ARTHROPLASTY; NONHUMAN; OSTEOARTHRITIS; PAGET BONE DISEASE; PATHOPHYSIOLOGY; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PREOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RHEUMATOID ARTHRITIS; RISK FACTOR; SENESCENCE; SEX DIFFERENCE; TESTIS INJURY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; HUMANS; OSSIFICATION, HETEROTOPIC; RISK FACTORS;

EID: 34249796649     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.89B4.18845     Document Type: Article

References (76)

1. Naraghi FF, DeCoster TA, Moneim MS, Miller RA, Rivero D. Heterotopic ossification. Orthopedics 1996;19:145-51.
2. Sawyer JR, Myers MA, Rosier RN, Puzas JE. Heterotopic ossification: clinical and cellular aspects. Calcif Tissue Int 1991;49:208-15.
3. Orzel JA, Rudd TG. Heterotopic bone formation: clinical, laboratory, and imaging correlation. J Nucl Med 1985;26:125-32.
4. Wilkinson JM, Stockley I, Hamer AJ, Barrington NA, Eastell R. Biomechanical markers of bone turnover and development of heterotopic ossification after total hip arthroplasty. J Orthop Res 2003;21:529-34.
5. Jowsey J, Coventry M, Robins PR. Heterotopic ossification: theoretical consideration possible etiological factors, and a clinical review of total hip arthroplasty patients exhibiting this phenomenon. In: The hip: procs 5th Open Scientific Meeting of the Hip Society. St Louis: CV Mosby, 1977201-21.
6. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement: incidence and a method of classification. J Bone Joint Surg [Am] 1973;55-A:1629-32.
7. Pohl F, Soufert J, Tauscher A, et al. The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty. Strahlenther Onkol 2005;181:529-33.
8. Schmidt J, Hackenbroch MH. A new classification for heterotopic ossifications in total hip arthroplasty considering the surgical approach. Arch Orthop Trauma Surg 1996:115:339-43.
9. Shafritz AB, Shore EM, Gannon FH. Overexpression of an osteogenic morphogen in fibrousclysplasia ossificans progressiva. N Engl J Med 1996;335:555-61.
10. Hannallah O, Peng H, Young B, et al. Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J Bone Joint Surg [Am] 2004;86-A:80-91.
11. Ahrengart L, Lindgren U, Reinholt FP. Comparative study of the effects of radiation, indomethacin, prednisilone and ethane-1-hydroxy-1, 1-disphonate (EHDP) in the prevention of ectopic bone formation. Clin Orthop 1988;229:265-73.
12. Charnley J. The long-term results of low friction arthroplasty of the hip performed as a primary intervention. J Bone Joint Surg [Br] 1972;54-B:61-76.
13. Rosendahl S, Christoffersen K, Norgaard M. Para-articular ossification following total hip replacement. Acta Orthop 1973;43:400-4.
14. Harris WH. Clinical results using Muller-Charnley total hip prosthesis. Clin Orthop 1972;86:95-101.
15. Ritter MA, Vaughan RB. Ectopic ossification after total hip arthroplasty: predisposing factors, frequency and effect on results. J Bone Joint Surg [Am] 1977;59-A:345-51.
16. DeLee J, Ferrari A, Charnley J. Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop 1976;121:53-9.
17. Chao ST, Lee SY, Borden LS, et al. External beam radiation helps prevent heterotopic bone formation in patients with a history of heterotopic ossification. J Arthroplasty 2006;21:731-6.
18. Dalury DF, Jiranek WA. The incidence of heterotopic ossification after total knee arthroplasty. J Arthrop1asty 2004;19:447-52.
19. Harwin SF, Stein AJ, Stern RE, Kulick RG. Heterotopic ossification following primary total knee arthroplasty. J Arthroplasty 1993;8:113-16.
20. Toyoda T, Matsumoto H, Tsuji T, Kinouchi J, Fujikawa K. Haterotopic ossification after total knee arthroplasty. J Arthroplasty 2003;18:1076.
21. Hasegawa M, Ohashi T, Uchida A. Heteratopic ossification around distal femur after total knee arthroplasty. Arch Orthop Trauma Surg 2002;122:274-8.
22. Rader CR Barthel T, Haase M, Scheidler M, Eulert J. Heterotopic ossification after total knee arthroplasty: 54/615 cases after 1-6 years' follow-up. Acta Orthop Scand 1997;68:46-50.
23. Furia JP, Pellegrini VD Jr. Heterotopic ossification following primary total knee arthroplasty. J Arthroplasty 1995;10:413-19.
24. Barrack RL, Brumfield CS, Rorabeck CH, Cleland D, Myers L. Heterotopic ossification after revision total knee arthroplasty. Clin Orthop 2002:404:208-13.
25. Ahrengart L. Periarticular heterotopic ossification after total hip arthroplasty: risk factors and consequences. Clin Orthop 1991;263:49-58.
26. Sundaram NA, Murphy JC. Heterotopic bone formation following total hip arthroplasty in ankylosing spondylitis. Clin Orthop 1986;207:223-6.
27. Fahrer H, Koch P, Ballmer P, Enzler P, Gerber N. Ectopic ossification following total hip arthroplasty: is diffuse idiopathic skeletal hyperostosis a risk factor? Br J Rheumatol 1988; 27:187-90.
28. Ashton AL, Bruce W, Goldberg J, Walsh W. Prevention of haterotopic bone formation in high risk patients post-total hip arthroplasty. J Orthop Surg 2000;8:53-7.
29. Morrey BF, Adams RA, Cabanela ME. Comparison of heterotopic bone after anterolateral, t ranstrochanteric, and posterior approaches for total hip arthroplasty. Clin Orthop 1984;188:160-7.
30. Purtill JJ, Eng K, Rothman RH, Hozack WJ. Heterotopic ossification: incidence in cemented versus cementless total hip arthroplasty. J Arthroplasty 1996;11:58-63.
31. Gebuhr P, Sletgard J, Alsgard J, et al. Heterotopic ossification after hip arthroplasty: a randomized double-blind multicenter study tenoxicam in 147 hips. Acta Orthop Scand 1996;67:29-32.
32. Maloney WJ, Krushell RJ, Jasty M, Harris WH. Incidence of heterotopic ossification after total hip replacement: effect of the type of fixation of the femoral component. J Bone Joint Surg [Am] 1991;73-A:191-3.
33. Nollen JG, Van Douveren FQ. Ectopic ossification in hip arthroplasty: a retrospective study of predisposing factors in 637 cases. Acta Orthop Scand 1993;64:185-7.
34. Rockwood PR, Horne JG. Heterotopic ossification following uncemented total hip arthroplasty. J Arthroplasty 1990;5(Suppl):43-6.
35. Velasco AD, Allan DB, Wroblewski BM. Psoas tenotomy and heterotopic ossification after Charnley low-friction arthroplasty. Clin Orthop 1993;291:193-5.
36. Cobb TK, Barry DJ, Wallrichs SL, Ilstrup DM, Morrey BF. Functional outcome of excision of heterotopic ossification after total hip arthroplasty. Clin Orthop 1999;361:131-9.
37. Freedman EL, Freedman DM. Heterotopic ossification following total knee arthroplasty requiring surgical excision. Am J Orthop 1996;25:559-61.
38. Padgett DE, Holley KG, Cummings M, et al. The efficacy of 500 CentiGray radiation in the prevention of heterotopic ossification after total hip arthroplasty: a prospective, randomized, pilot study. J Arthroplasty 2003;18:677-86.
39. Vesell ES. Failure of indomethacin and warfarin to interact in normal healthy volunteers. J Clin Pharmacol 1975;15:486-95.
40. Fransen M, Neal B. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst Rev 2004;3:CD001160.
41. Burd TA, Lowry KJ, Anglen JO. Indomethacin compared with localized irradiation for the prevention of heterotopic ossification following surgical treatment of acetabular fractures. J Bone Joint Surg [Am] 2001;83-A:1783-8.
42. Matta JM, Siebenrock KA. Does indomethacin reduce heterotopic bone formation after operations for acetabular fractures?: a prospective randomised study. J Bone Joint Surg [Br] 1997;79-B:959-63.
43. McLaren AC. Prophylaxis with indomethacin for heterotopic bone after open reduction of fractures of the acetabulum. J Bone Joint Surg [Am] 1990;72-A:245-7.
44. Kjaersgaard-Andersen P, Nafei A, Teichert G, et al. Indomethacin for prevention of heterotopic ossification: a randomized controlled study in 41 hip arthroplasties. Acta Orthop Scand 1993;64:639-42.
45. Burd TA, Hughes MS, Anglen JO. Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion. J Bone Joint Surg [Br] 2003:85-13:700-5.
46. Fransen M, Anderson C, Douglas J, et al. Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial. BMJ 2006;333:519.
47. Pellegrini VD Jr, Konski AA, Gastel JA, Rubin P, Evarts CM. Prevention of heterotopic ossification with irradiation after total hip arthroplasty: radiation therapy with a single dose of eight hundred centigray administered to a limited field. J Bone Joint Surg [Am] 1992;74-A:186-200.
48. Lo TC, Healy WIL, Covell DJ. Heterotopic bone formation after hip surgery: prevention with single dose postoperative hip irradiation. Radiology 1988;168:851-4.
49. Gregoritch SJ, Chadha M, Pelligrini VD, Rubin R Kantorowitz DA. Randomized trial comparing preoperative versus postoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement: preliminary results. Int J Radiat Oncol Biol Phys 1994;30:55-62.
50. Cooley LM, Goss RJ. The effects of transplantation and x-irradiation on the repair of fractured bones. Am J Anat 1958;102:167-81.
51. Craven PL, Urist MR. Osteogenesis by radioisotope labelled cell populations in implants of bone matrix under the influence of ionizing radiation. Clin Orthop 1971;76:231-3.
52. Coventry MB, Scanlon PW. The use of radiation to discourage ectopic bone: a nine-year study in surgery about the hip. J Bone Joint Surg [Am] 1981;63-A:201-8.
53. Sylvester JE, Greenberg P, Selch MT, Thomas BJ, Amstutz H. The use of post-operative irradiation for the prevention of heterotopic bone formation after total hip replacement. Int J Radiat Oncol Biol Phys 1998;14:471-6.
54. Healy WL, Lo TC, DeSimone AA, Rask B, Pfeifer BA. Single-dose irradiation for the prevention of heterotopic ossification after total hip arthroplasty: a comparison of doses of five hundred and fifty and seven hundred centigray. J Bone Joint Surg [Am] 1995;77-A:590-5.
55. Seegenschmiedt MH, Keilholz L, Martus P, et al. Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy. Int J hadiat Oncol Biol Phys 1997;39:161-71.
56. Konski A. The use of postoperative irradiation for the prevention of HO after THA with biologic fixation (porous coated) prosthesis: an animal model. Int J Radiat Oncol Biol Phys 1990;18:861-5.
57. Jasty M. Radiation-blocking shields. Clin Orthop 1990;257:138-45.
58. Kim J. Radiation induced soft tissue and bone sarcomas. Radiology 1978;129:501-8.
59. Patel HYC, Silverman CL, Carrascosa L, et al. Evaluation of scrotal and testicular dose when using radiation for heterotopic ossification prophylaxis. Int J Radiat Oncol Biol Phys 2005;63:340-1.
60. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 2005;34:12-7.
61. Kinsella TJ, Trivette G, Rowland J, et al. Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin's disease. J Clin Oncol 1989;7:718-24.
62. Wroblewski BM, Shelley P. Reattachment of the greater trochanter after hip replacement. J Bone Joint Surg [Br] 1985;67-B:736-40.
63. Hofmann S, Trnka HJ, Metzenroth H, et al. General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty. Orthopedics 1999;22:207-11.
64. Barthel T, Baumann B, Noth U, Eulert J. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam. Acta Orthop Scand 2002;73:611-14.
65. van Leeuwen WM, Deckers P, do Lange WJ. Preoperative irradiation for prophylaxis of ectopic ossification after hip arthroplasty: a randomized study in 62 hips. Acta Orthop Scand 1998;69:116-18.
66. Neal BC, Rodgers A, Clark T, et al. A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand 2000;71:122-8.
67. Kolbl O, Knelles D, Barthel T, et al. Preoperative irradiation versus the use of non-steroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial. Int J Radiat Oncol Biol Phys 1998;42:397-401.
68. Knelles D, Barthel T, Karrer A, et al. Prevention of heterotopic ossification after total hip replacement: a prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation. J Bone Joint Surg [Br] 1997;79-B:596-602.
69. Kolbl O, Knelles D, Barthel T, et al. Randomized trial comparing early postoperative irradiation vs the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement. Int J Radiat Oncol Biol Phys 1997;39:961-6.
70. Sell S. Willms R, Jany R, et al. The suppression of heterotopic ossifications: radiation versus NSAID therapy: a prospective study. J Arthroplasty 1998;13:854-9.
71. Bremen-Kuhne R, Stock D, Franke C. Indomethacin: short-term therapy vs. single low dosage radiation for prevention of periarticular ossifications after total hip endoprosthesis. Z Orthop Ihre Grenzgeb 1997;135:422-9 (in German).
72. Kienapfel H, Koller M, Wust A, et al. Prevention of heterotopic bone formation after total hip arthroplasty: a prospective randomised study comparing postoperative radiation therapy with indomethacin medication. Arch Orthop Trauma Surg 1999;119:296-302.
73. Pakos EE, Ioannidis JP. Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a metal-analysis of randomized trials. Int J Radiat Oncol Biol Phys 2004;60:888-95.
74. Moed BR, Letournel E. Low-dose irradiation and indomethacin prevent heterotopic ossification after acetabular fracture surgery. J Bone Joint Surg [Br] 1994;76-B:895-900.
75. Pakos EE, Pitouli EJ, Tsekeris PG, et al. Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol. Int Orthop 2006;30:79-83.
76. Piatek S, Westphal T, Arbter D, Winckler S. Value of a combined ossification prophylaxis with indomethacin and radiotherapy for acetabular fractures. Unfallchirurg 2006;109:556-62 (in German).